Aptevo Therapeutics Inc. Accounts Payable
Aptevo Therapeutics Inc. (APVO) had Accounts Payable of $1.16 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.16M.
- 2026-03-31: Accounts Payable, Current $890.00K.
- 2025-12-31: Accounts Payable, Current $877.00K.
- 2024-12-31: Accounts Payable, Current $1.24M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.16M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $890.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $877.00K 10-Q · filed 2026-08-14 |
| 2024-12-31 | $1.24M 10-K · filed 2026-03-26 |
| 2020-06-30 | $4.66M 10-Q · filed 2020-08-14 |
| 2019-12-31 | $6.43M 10-Q · filed 2020-08-14 |
| 2019-09-30 | $12.07M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $11.90M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $11.04M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.67M 10-Q · filed 2019-11-07 |
| 2016-06-30 | $11.19M 10-Q/A · filed 2016-09-22 |
| 2015-12-31 | $10.08M 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |